CHANDRA, A. . Identification of biorelevant dissolution media to assess biopharmaceutical performance of erlotinib formulation with enhanced bioavailability using physiologybased pharmacokinetic modeling. Asian Journal of Pharmaceutics (AJP), [S. l.], v. 16, n. 2, 2022. DOI: 10.22377/ajp.v16i2.4389. Disponível em: https://asiapharmaceutics.info/index.php/ajp/article/view/4389. Acesso em: 29 sep. 2022.